Skip to content

Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.

Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia. Analysis of Risk Factors and Impact on the Outcome.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01683487
Enrollment
122
Registered
2012-09-11
Start date
2012-10-31
Completion date
2014-05-31
Last updated
2014-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-acquired Pneumonia

Brief summary

I. To investigate time measurement from emergency room admission to first antibiotic administration. II. To evaluate risk factors for prolonged time to first antibiotic administration. III. To correlate time measurement with Charlson comorbidity index and multimorbidity patterns. IV. To investigate the impact of a delayed time to first antibiotic administration on the outcome

Detailed description

In this retrospective cohort study, we plan to include all patients presenting with a community-acquired pneumococcal pneumonia at the University Hospital of Zurich between January 1, 2006 and June 30, 2012 (6½ years). The patients will be identified either with one or more blood culture pairs positive for S. pneumoniae or with a positive pneumococcal urine antigen assay in combination with the clinical diagnosis of CAP, which was based on the presence of select clinical features (e.g., cough, fever, sputum production, and pleuritic chest pain) and is supported by imaging of the lung, usually by chest radiography according to Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of CAP in adults \[11\]. CAP is not considered if the patient is discharged from a hospital less than 7 days before the current hospital admission, if the first blood culture or urinary antigen assay is obtained more than 1 week after hospital admission, or if the patient has no clinical diagnosis of CAP at the time of admission. Patients referred from or transferred to another hospital are excluded. After identification of eligible patients upon microbiological results, medical records are reviewed using a standardized data collection questionnaire. Comorbidity is determined using the Charlson comorbidity index \[10\]. Additionally, all patients are classified according to the multimorbidity patterns proposed by Holden et al. \[12\]. These are: 1. arthritis, osteoporosis, other chronic pain, bladder problems, and irritable bowel; 2. asthma, chronic obstructive pulmonary disease, and allergies; 3. back/neck pain, migraine, other chronic pain, and arthritis; 4. high blood pressure, high cholesterol, obesity, diabetes, and fatigue; 5. cardiovascular disease, diabetes, fatigue, high blood pressure, high cholesterol, and arthritis; and 6. irritable bowel, ulcer, heartburn, and other chronic pain. Time calculation is based upon the moment of emergency room (ER) admission.

Interventions

PROCEDUREObservation

Observational study only, no intervention.

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients with community-acquired pneumococcal pneumonia, which was confirmed by 1. detection of Streptococcus pneumoniae in blood cultures, tracheal secretion or sputum OR/AND 2. positive urinary pneumococcal antigen AND 3. presence of cough and presence of one of the following signs/symptoms: new focal chest signs; dyspnoea; tachypnoea; fever AND 4. radiologic signs of pneumonia

Exclusion criteria

- Pneumonia of other cause (e.g. non-pneumococcal pneumonia) * Hospital-acquired or ventilator-associated pneumonia * Patients referred from or transferred to another hospital

Design outcomes

Primary

MeasureTime frameDescription
In-hospital mortaliyFrom day of admission until discharge or deadMortality during hospitalization because of pneumococcal pneumonia

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026